https://oskar-bordeaux.fr:443 The DSpace digital repository system captures, stores, indexes, preserves, and distributes digital research material. 2026-05-30T18:59:43Z https://oskar-bordeaux.fr/handle/20.500.12278/172974 Bulletin BiblioDem 2023-20-03 COMITÉ DE RÉDACTION BIBLIODEM Articles analysés dans ce numéro : 1. Bancks MP, Byrd GS, Caban-Holt A, Fitzpatrick AL, Forrester SN, Hayden KM, et al. Self-reported experiences of discrimination and incident dementia. Alzheimers Dement. 2023. 2. Dubbelman MA, Sikkes SAM, Ebenau JL, van Leeuwenstijn M, Kroeze LA, Trieu C, et al. Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe project. Alzheimers Dement. 2023. 3. Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, et al. Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study. Brain. 2023. 4. Grasset L, Power MC, Crivello F, Tzourio C, Chene G, Dufouil C. How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort. J Alzheimers Dis. 2023;92(1):183-93. 5. Huang AR, Roth DL, Cidav T, Chung SE, Amjad H, Thorpe RJ, Jr., et al. Social isolation and 9-year dementia risk in community-dwelling Medicare beneficiaries in the United States. J Am Geriatr Soc. 2023;71(3):765-73. 6. Jia J, Zhao T, Liu Z, Liang Y, Li F, Li Y, et al. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. BMJ. 2023;380:e072691. 7. Salvado G, Larsson V, Cody KA, Cullen NC, Jonaitis EM, Stomrud E, et al. Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study. Alzheimers Dement. 2023. 2023-03-20T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/172287 Bulletin BiblioDem 2023-20-02 COMITE DE REDACTION BIBLIODEM Articles analysés dans ce numéro 1. Anantapong K, Davies N, Sampson EL. Communication between the multidisciplinary team and families regarding nutrition and hydration for people with severe dementia in acute hospitals: a qualitative study. Age Ageing. 2022;51(11). 2. Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH, et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study. Lancet Neurol. 2023;22(1):55-65. 3. Burgdorf JG, Amjad H. Impact of diagnosed (vs undiagnosed) dementia on family caregiving experiences. J Am Geriatr Soc. 2022. 4. de Crom TOE, Ginos BNR, Oudin A, Ikram MK, Voortman T, Ikram MA. Air Pollution and the Risk of Dementia: The Rotterdam Study. J Alzheimers Dis. 2023;91(2):603-13. 5. Felstead C, Perkins L, Stott J, Hui EK, Spector A. A systematic literature review of group-based training interventions for informal carers: impact on the behavioural and psychological symptoms of dementia (BPSD). Aging Ment Health. 2022:1-10. 6. Gotanda H, Tsugawa Y, Xu H, Reuben DB. Life satisfaction among persons living with dementia and those without dementia. J Am Geriatr Soc. 2022. 7. Huang AR, Rebok GW, Swenor BK, Reed N, Griswold M, Zhu X, et al. Concurrent hearing and vision impairment and 8-year memory decline in community-dwelling older adults. Alzheimers Dement. 2022. 8. Kleineidam L, Wagner M, Guski J, Wolfsgruber S, Miebach L, Bickel H, et al. Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia. Alzheimers Dement. 2022. 9. Li J, Liu C, Ang TFA, Au R. BMI decline patterns and relation to dementia risk across four decades of follow-up in the Framingham Study. Alzheimers Dement. 2022. 10. Sutin AR, Luchetti M, Aschwanden D, Zhu X, Stephan Y, Terracciano A. Loneliness and risk of all-cause, Alzheimer's, vascular, and frontotemporal dementia: a prospective study of 492,322 individuals over 15 years. Int Psychogeriatr. 2022:1-10. 11. Therriault J, Vermeiren M, Servaes S, Tissot C, Ashton NJ, Benedet AL, et al. Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography. JAMA Neurol. 2023;80(2):188-99. 12. van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023;388(1):9-21. 2023-02-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/172284 Bulletin BiblioDem 2023-20-01 COMITE DE REDACTION BIBLIODEM 2023-02-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/183459 Bulletin BiblioDem 2023-20-05 COMITÉ DE RÉDACTION BIBLIODEM, / Articles analysés dans ce numéro 1. Cheng Y, Zamrini E, Faselis C, Redd D, Shao Y, Morgan CJ, et al. Cardiorespiratory fitness and risk of Alzheimer's disease and related dementias among American veterans. Alzheimers Dement. 2023. 2. Lavallée PC, Charles H, Albers GW, Caplan LR, Donnan GA, Ferro JM, et al. Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study. Lancet Neurol. 2023;22(4):320-9. 3. Liu C, Ma Y, Hofman A, Waziry R, Koton S, Pike JR, et al. Educational Attainment and Dementia: Mediation by Mid-Life Vascular Risk Factors. Ann Neurol. 2023. 4. Lucey BP, Liu H, Toedebusch CD, Freund D, Redrick T, Chahin SL, et al. Suvorexant acutely decreases tau phosphorylation and Aβ in the human CNS. Ann Neurol. 2023. 5. McMaster M, Kim S, Clare L, Torres SJ, Cherbuin N, Anstey KJ. The feasibility of a multidomain dementia risk reduction randomised controlled trial for people experiencing cognitive decline: the Body, Brain, Life for Cognitive Decline (BBL-CD). Aging Ment Health. 2023:1-9. 6. Ueda P, Pasternak B, Lim CE, Neovius M, Kader M, Forssblad M, et al. Neurodegenerative disease among male elite football (soccer) players in Sweden: a cohort study. Lancet Public Health. 2023. 7. Van Orden KA, Bower E, Lutz J, Silva C. Engage coaching for caregivers: a pilot trial to reduce loneliness in dementia caregivers. Aging Ment Health. 2023:1-8. 2023-07-20T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/182344 Bulletin BiblioDem 2023-20-04  COMITÉ DE RÉDACTION BIBLIODEM, / 1. Charisis S, Lin H, Ray R, Joehanes R, Beiser AS, Levy D, et al. Obesity impacts the expression of Alzheimer's disease-related genes: The Framingham Heart Study. Alzheimers Dement. 2023. 2. Dubois B, Lopez-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, et al. Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial. Alzheimers Res Ther. 2023;15(1):39. 3. Gao L, Li P, Gaykova N, Zheng X, Gao C, Lane JM, et al. Circadian Rest-Activity Rhythms, Delirium Risk, and Progression to Dementia. Ann Neurol. 2023. 4. Grodstein F, Leurgans SE, Capuano AW, Schneider JA, Bennett DA. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023;80(4):370-6. 5. Guo J, Song S. Associations of height loss with cognitive decline and incident dementia in adults aged 50 years and older. J Gerontol A Biol Sci Med Sci. 2023. 6. Karamacoska D, Tan T, Mathersul DC, Sabag A, de Manincor M, Chang D, et al. A systematic review of the health effects of yoga for people with mild cognitive impairment and dementia. BMC Geriatr. 2023;23(1):37. 7. Li N, Deng Q, Yang Q, Wang Y, Hu J, Zhao X, et al. Effect of physical activity intervention on cognitive function in China: A cluster randomized trial. Alzheimers Dement. 2023. 8. Petersen RC, Aisen PS, Andrews JS, Atri A, Matthews BR, Rentz DM, et al. Expectations and clinical meaningfulness of randomized controlled trials. Alzheimers Dement. 2023. 9. Yu X, Westrick AC, Kobayashi LC. Cumulative loneliness and subsequent memory function and rate of decline among adults aged >/=50 in the United States, 1996 to 2016. Alzheimers Dement. 2023;19(2):578-88. 2023-05-25T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/188591 Bulletin BiblioDem 2023-20-11/12 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants ont été analysés. 1. Aiken-Morgan AT, Capuano AW, Wilson RS, Barnes LL. Changes in Body Mass Index and Incident Mild Cognitive Impairment Among African American Older Adults. J Gerontol A Biol Sci Med Sci. 2023;79(3). 2. Edwards AL, Collins JA, Junge C, Kordasiewicz H, Mignon L, Wu S, et al. Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial. JAMA Neurol. 2023;80(12):1344-52. 3. Himali JJ, Baril AA, Cavuoto MG, Yiallourou S, Wiedner CD, Himali D, et al. Association Between Slow-Wave Sleep Loss and Incident Dementia. JAMA Neurol. 2023;80(12):1326-33. 4. Lee D, Slomkowski M, Hefting N, Chen D, Larsen KG, Kohegyi E, et al. Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial. JAMA Neurol. 2023;80(12):1307-16. 5. Pyer M, Ward A. Developing a dementia friendly approach to consent in dementia research. Aging Ment Health. 2024;28(2):294-301. 6. Reboucas SCL, Cougnard-Gregoire A, Arnould L, Delyfer MN, Schweitzer C, Korobelnik JF, et al. Retinal microvasculature and incident dementia over 10 years: The Three-City-Alienor cohort. Alzheimers Dement (Amst). 2023;15(4):e12480. 7. Saltiel N, Tripodis Y, Menzin T, Olaniyan A, Baucom Z, Yhang E, et al. Relative Contributions of Mixed Pathologies to Cognitive and Functional Symptoms in Brain Donors Exposed to Repetitive Head Impacts. Ann Neurol. 2024;95(2):314-24. 8. Yu DSF, Cheng ST, Chow EO, Kwok T, McCormack B, Wu W. The effects of a salutogenic strength-based intervention on sense of coherence and health outcomes of dementia family carers: A randomized controlled trial. Age Ageing. 2023;52(9). 2024-02-23T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/186343 Bulletin BiblioDem 2023-20-10 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants ont été analysés : 1. Ferrante FJ, Migeot J, Birba A, Amoruso L, Perez G, Hesse E, et al. Multivariate word properties in fluency tasks reveal markers of Alzheimer's dementia. Alzheimers Dement. 2023. 2. Chanti-Ketterl M, Pieper CF, Yaffe K, Plassman BL. Associations Between Traumatic Brain Injury and Cognitive Decline Among Older Male Veterans: A Twin Study. Neurology. 2023;101(18):e1761-e70. 3. de Crom TOE, Steur M, Ikram MK, Ikram MA, Voortman T. Plant-based dietary patterns and the risk of dementia: a population-based study. Age Ageing. 2023;52(9). 4. Devanand DP, Goldberg TE, Qian M, Rushia SN, Sneed JR, Andrews HF, et al. Computerized Games versus Crosswords Training in Mild Cognitive Impairment. NEJM Evid. 2022;1(12). 5. Qureshi D, Collister J, Allen NE, Kuzma E, Littlejohns T. Association between metabolic syndrome and risk of incident dementia in UK Biobank. Alzheimers Dement. 2023. 6. Sala G, Nishita Y, Tange C, Shu Z, Ando F, Shimokata H, et al. Differential longitudinal associations between domains of cognitive function and physical function: A 20-year follow-up study. J Gerontol B Psychol Sci Soc Sci. 2023. 7. Qureshi D, Collister J, Allen NE, Kuzma E, Littlejohns T. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. JAMA Neurol. 2023. 8. Zulke AE, Pabst A, Luppa M, Roehr S, Seidling H, Oey A, et al. A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial. Alzheimers Dement. 2023. 2023-12-04T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/188796 Bulletin BiblioDem 2024-21-1 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants ont été analysés. 1. Amano T, Halvorsen CJ, Kim S, Reynolds A, Scher C, Jia Y. An outcome-wide analysis of the effects of diagnostic labeling of Alzheimer's disease and related dementias on social relationships. Alzheimers Dement. 2023. 2. Lachner C, Craver EC, Babulal GM, Lucas JA, Ferman TJ, White RO, et al. Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans. Ann Neurol. 2024;95(3):518-29. 3. Roncarati JS, DeVone F, Halladay C, Tsai J, Jutkowitz E. Risk of dementia among veterans experiencing homelessness and housing instability. J Am Geriatr Soc. 2024;72(2):382-9. 4. Shulman M, Kong J, O'Gorman J, Ratti E, Rajagovindan R, Viollet L, et al. TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease. Nat Aging. 2023;3(12):1591-601. 5. Yaffe K, Vittinghoff E, Dublin S, Peltz CB, Fleckenstein LE, Rosenberg DE, et al. Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical Trial. JAMA Intern Med. 2024;184(1):54-62. 2024-03-14T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/184513 Bulletin BiblioDem 2023 20-6/7 COMITÉ DE RÉDACTION BIBLIODEM, / Articles analysés dans ce numéro : 1. Coleman ME, Roessler MEH, Peng S, Roth AR, Risacher SL, Saykin AJ, et al. Social enrichment on the job: Complex work with people improves episodic memory, promotes brain reserve, and reduces the risk of dementia. Alzheimers Dement. 2023;19(6):2655-65. 2.Evans CD, Sparks J, Andersen SW, Brooks DA, Hauck PM, Mintun MA, et al. APOE epsilon4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials. Alzheimers Dement. 2023. 3. Garnier-Crussard A, Cotton F, Krolak-Salmon P, Chetelat G. White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution. Alzheimers Dement. 2023;19(8):3738-48. 4. Moran C, Lacy ME, Whitmer RA, Tsai AL, Quesenberry CP, Karter AJ, et al. Glycemic Control Over Multiple Decades and Dementia Risk in People With Type 2 Diabetes. JAMA Neurol. 2023;80(6):597-604. 5. Sachs BC, Williams BJ, Gaussoin SA, Baker LD, Manson JE, Espeland MA, et al. Impact of multivitamin-mineral and cocoa extract on incidence of mild cognitive impairment and dementia: Results from the COcoa Supplement and Multivitamin Outcomes Study for the Mind (COSMOS-Mind). Alzheimers Dement. 2023. 6. Wilker EH, Osman M, Weisskopf MG. Ambient air pollution and clinical dementia: systematic review and meta-analysis. BMJ. 2023;381:e071620. 7. Windle G, Roberts J, MacLeod C, Algar-Skaife K, Sullivan MP, Brotherhood E, et al. 'I have never bounced back': resilience and living with dementia. Aging Ment Health. 2023;27(12):2355-67. 8. Wong ATY, Reeves GK, Floud S. Total sleep duration and daytime napping in relation to dementia detection risk: Results from the Million Women Study. Alzheimers Dement. 2023. 9. Zhong W, Chen H, Gong X, Tong L, Xu X, Zong G, et al. Prevalent stroke, age of its onset, and post-stroke lifestyle in relation to dementia: A prospective cohort study. Alzheimers Dement. 2023;19(9):3998-4007. 2023-10-24T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/186158 Bulletin BiblioDem 2023-20-8/9 COMITÉ DE RÉDACTION BIBLIODEM, / 1. Grasset L, Planche V, Bouteloup V, Azouani C, Dubois B, Blanc F, et al. Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort. Alzheimers Dement. 2023. 2. Hirabayashi N, Honda T, Hata J, Furuta Y, Shibata M, Ohara T, et al. Association Between Frequency of Social Contact and Brain Atrophy in Community-Dwelling Older People Without Dementia: The JPSC-AD Study. Neurology. 2023;101(11):e1108-e17. 3. Johansen MC, Ye W, Gross A, Gottesman RF, Han D, Whitney R, et al. Association Between Acute Myocardial Infarction and Cognition. JAMA Neurol. 2023;80(7):723-31. 4. Jonsson L, Wimo A, Handels R, Johansson G, Boada M, Engelborghs S, et al. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint. Lancet Reg Health Eur. 2023;29:100657. 5. Nelson PT, Schneider JA, Jicha GA, Duong MT, Wolk DA. When Alzheimer's is LATE: Why Does it Matter? Ann Neurol. 2023;94(2):211-22. 6. Oostra DL, Nieuwboer MS, Melis RJF, Remers TEP, Olde Rikkert MGM, Perry M. DementiaNet facilitates a sustainable transition toward integrated primary dementia care: A long-term evaluation. Alzheimers Dement. 2023. 7. Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, et al. Trial of Solanezumab in Preclinical Alzheimer's Disease. N Engl J Med. 2023;389(12):1096-107. 8. Wiese LAK, Gibson A, Guest MA, Nelson AR, Weaver R, Gupta A, et al. Global rural health disparities in Alzheimer's disease and related dementias: State of the science. Alzheimers Dement. 2023;19(9):4204-25. 2023-11-27T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/200366 Bulletin BiblioDem 2024-21-2/3 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants ont été analysés : 1. Adesuyan M, Jani YH, Alsugeir D, Howard R, Ju C, Wei L, et al. Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study. Neurology. 2024;102(4):e209131. 2. Beck ED, Yoneda T, James BD, Bennett DA, Hassenstab J, Katz MJ, et al. Personality predictors of dementia diagnosis and neuropathological burden: An individual participant data meta-analysis. Alzheimers Dement. 2023. 3. Biesbroek JM, Coenen M, DeCarli C, Fletcher EM, Maillard PM, Barkhof F, et al. Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients. Alzheimers Dement. 2024;20(4):2980-9. 4. Cantuaria ML, Pedersen ER, Waldorff FB, Wermuth L, Pedersen KM, Poulsen AH, et al. Hearing Loss, Hearing Aid Use, and Risk of Dementia in Older Adults. JAMA Otolaryngol Head Neck Surg. 2024;150(2):157-64. 5. Dhana K, Agarwal P, James BD, Leurgans SE, Rajan KB, Aggarwal NT, et al. Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia. JAMA Neurol. 2024;81(3):233-9. 6. Gu Y, Honig LS, Kang MS, Bahl A, Sanchez D, Reyes-Dumeyer D, et al. Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort. Alzheimers Dement. 2024. 7. Hendriks S, Ranson JM, Peetoom K, Lourida I, Tai XY, de Vugt M, et al. Risk Factors for Young-Onset Dementia in the UK Biobank. JAMA Neurol. 2024(2):134-42. 8. Huh J, Arpawong TE, Gruenewald TL, Fisher GG, Prescott CA, Manly JJ, et al. General cognitive ability in high school, attained education, occupational complexity, and dementia risk. Alzheimers Dement. 2024;20(4):2662-9. 9. Phan TX, Baratono S, Drew W, Tetreault AM, Fox MD, Darby RR, et al. Increased Cortical Thickness in Alzheimer's Disease. Ann Neurol. 2024. 10. Shimada H, Doi T, Tsutsumimoto K, Makino K, Harada K, Tomida K, et al. Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation. J Alzheimers Dis. 2024;98(2):659-69. 2024-06-10T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/201065 Bulletin BiblioDem 2024-21-4/5 COMITÉ DE RÉDACTION BIBLIODEM, / Dans de numéro, les articles suivants ont été analysés : 1. Freedman VA, Cornman JC. Dementia Prevalence, Incidence and Mortality Trends Among US Adults Ages 72 and Older, 2011-2021. J Gerontol A Biol Sci Med Sci. 2024. 2. Ghanem A, Berry DS, Burkes A, Grill N, Hall TM, Hart KA, et al. Prevalence of and Annual Conversion Rates to Mild Cognitive Impairment and Dementia: Prospective, Longitudinal Study of an Essential Tremor Cohort. Ann Neurol. 2024;95(6):1193-204. 3. Kouri N, Frankenhauser I, Peng Z, Labuzan SA, Boon BDC, Moloney CM, et al. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease. JAMA Neurol. 2024;81(6):619-29. 4. Tesi N, van der Lee S, Hulsman M, van Schoor NM, Huisman M, Pijnenburg Y, et al. Cognitively healthy centenarians are genetically protected against Alzheimer's disease. Alzheimers Dement. 2024;20(6):3864-75. 5. Hernández-Ruiz V, Roubaud-Baudron C, Von Campe H, Retuerto N, Mégraud F, Helmer C, et al. Association between Helicobacter pylori infection and incident risk of dementia: The AMI cohort. J Am Geriatr Soc. 2024;72(4):1191-8. 6. Saadmaan G, Dalmasso MC, Ramirez A, Hiltunen M, Kemppainen N, Lehtisalo J, et al. Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial. Alzheimers Dement. 2024;20(6):4345-50. 2024-07-23T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/204663 Bulletin BiblioDem 2024-21-7 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants ont été analysés : 1. Belloy ME, Le Guen Y, Stewart I, Williams K, Herz J, Sherva R, et al. Role of the X Chromosome in Alzheimer Disease Genetics. JAMA Neurol. 2024;81(10):1032-42. 2. Engels-Domínguez N, Riphagen JM, Van Egroo M, Koops EA, Smegal LF, Becker JA, et al. Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals. Ann Neurol. 2024;96(4):650-61. 3. Lao P, Young CB, Ezeh C, Lacayo B, Seblova D, Andrews RM, et al. Loneliness, cerebrovascular and Alzheimer's disease pathology, and cognition. Alzheimers Dement. 2024;20(10):7113-23. 4. Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, et al. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care. JAMA. 2024;332(15):1245-57. 5. Sewell KR, Doecke JD, Xiong C, Benzinger T, Masters CL, Laske C, et al. Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease. Alzheimers Dement. 2024;20(11):7923-39. 6. Yu L, Aziz AUR, Zhang X, Li W. Investigating the causal impact of different types of physical activity on psychiatric disorders across life stages: A Mendelian randomization study. J Affect Disord. 2024;365:606-13. 2024-08-30T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/204597 Bulletin BiblioDem 2024-21-08 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants ont été analysés : 1. Balamurali BT, Jer-Ming C. Performance Assessment of ChatGPT versus Bard in Detecting Alzheimer's Dementia. Diagnostics (Basel). 2024;14(8). 2. Brier MR, Schindler SE, Salter A, Perantie D, Shelley N, Judge B, et al. Unexpected Low Rate of Amyloid-beta Pathology in Multiple Sclerosis Patients. Ann Neurol. 2024;96(3):453-9. 3. Chen Y, Power MC, Grodstein F, Capuano AW, Lange-Maia BS, Moghtaderi A, et al. Correlates of missed or late versus timely diagnosis of dementia in healthcare settings. Alzheimers Dement. 2024;20(8):5551-60. 4. Kang M, Li C, Mahajan A, Spat-Lemus J, Durape S, Chen J, et al. Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment. JAMA Psychiatry. 2024;81(10):993-1002. 5. Knopman DS, Pike JR, Gottesman RF, Sharrett AR, Windham BG, Mosley TH, Jr., et al. Patterns of cognitive domain abnormalities enhance discrimination of dementia risk prediction: The ARIC study. Alzheimers Dement. 2024;20(7):4559-71. 2024-10-30T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/204524 Bulletin BiblioDem 2024-21-06 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants ont été analysés : 1. Hu W, Zhang WB, Liu BP, Jia CX. Associations and Mediating Pathways Between Childhood Adversity and Risk of Dementia: A Cohort Study in the UK Biobank. J Gerontol A Biol Sci Med Sci. 2024;79(8). 2. Kazibwe R, Schaich CL, Muhammad AI, Epiu I, Namutebi JH, Chevli PA, et al. Effect of vigorous-intensity physical activity on incident cognitive impairment in high-risk hypertension. Alzheimers Dement. 2024;20(7):4602-12. 3. Mobley AR, Subramanian A, Champsi A, Wang X, Myles P, McGreavy P, et al. Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk. Nat Med. 2024;30(8):2288-94. 4. Neal DP, Kucera M, van Munster BC, Ettema TP, Dijkstra K, Muller M, et al. Cost-effectiveness of the FindMyApps eHealth intervention vs. digital care as usual: results from a randomised controlled trial. Aging Ment Health. 2024;28(11):1457-70. 5. Ramos-Cejudo J, Corrigan JK, Zheng C, Swinnerton KN, Jacobson SR, La J, et al. Antidepressant exposure and long-term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder. Alzheimers Dement. 2024;20(6):4106-14. 6. Wagemann O, Liu H, Wang G, Shi X, Bittner T, Scelsi MA, et al. Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial. JAMA Neurol. 2024;81(6):582-93. 2024-07-08T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207365 Bulletin BiblioDem 2025-22-1 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants sont analysés : 1. Aunsmo RH, Strand BH, Anstey KJ, Bergh S, Kivimaki M, Kohler S, et al. Associations between depression and anxiety in midlife and dementia more than 30 years later: The HUNT Study. Alzheimers Dement (Amst). 2024;16(4):e70036. 2. Benussi A, Huber H, Tan K, Cantoni V, Rivolta J, Cotelli MS, et al. Plasma p-tau(217) and neurofilament/p-tau(217) ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration. Alzheimers Dement. 2025;21(2):e14482. 3. Chen Y, Grodstein F, Capuano AW, Wang T, Bennett DA, James BD. Late-life social activity and subsequent risk of dementia and mild cognitive impairment. Alzheimers Dement. 2025;21(1):e14316. 4. Marseglia A, Dartora C, Samuelsson J, Poulakis K, Mohanty R, Shams S, et al. Biological brain age and resilience in cognitively unimpaired 70-year-old individuals. Alzheimers Dement. 2025;21(2):e14435. 5. Qureshi D, Luben R, Hayat S, Talarico R, Allen NE, Kuzma E, et al. Role of age and exposure duration in the association between metabolic syndrome and risk of incident dementia: a prospective cohort study. Lancet Healthy Longev. 2024;5(12):100652. 6. van Lent DM, Mesa HG, Short MI, Gonzales MM, Aparicio HJ, Salinas J, et al. Association between dietary inflammatory index score and incident dementia. Alzheimers Dement. 2025;21(1):e14390. 2025-02-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207368 Bulletin BiblioDem 2025-22-4 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants sont analysés : 1. Blandi L, Bertuccio P, Signorelli C, Brand H, Clemens T, Renzi C, et al. Herpes zoster as risk factor for dementia: a matched cohort study over 20 years in a 10-million population in Italy. J Prev Alzheimers Dis. 2025:100167. 2. Eyting M, Xie M, Michalik F, Hess S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641(8062):438-46. 3. Imamura K, Kawai H, Ejiri M, Sasai H, Ihara K, Nakada H, et al. Association between the use of information and communication technology and cognitive decline stratified by social isolation: The Otassha study. J Prev Alzheimers Dis. 2025:100138. 4. Moses Appel A, Jensen-Dahm C, Munk Laursen T, Waldemar G, Janbek J. The Effect of Influenza Vaccination on Hospitalization and Mortality Among People With Dementia. J Am Geriatr Soc. 2025;73(5):1498-505. 5. Myran DT, Pugliese M, Harrison LD, Stall NM, Webber C. Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis. JAMA Neurol. 2025;82(6):570-9. 6. Oh HS, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, et al. A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's disease. Nat Med. 2025;31(5):1592-603. 7. Pansieri J, Pisa M, Yee S, Gutnikova A, Ridgeon E, Hickman R, et al. Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex. Ann Neurol. 2025(6):1067-73. 8. Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes Zoster Vaccination and Dementia Occurrence. JAMA. 2025;333(23):2083-92. 9. Wang Y, Zang EX, Davis-Plourde K, Vander Wyk B, Gill TM, Becher RD. Incidence of Frailty, Dementia, and Disability Among Community-Living Older Americans According to County-Level Disadvantage. J Am Geriatr Soc. 2025(6):1847-56. 10. Zimmer JA, Ardayfio P, Wang H, Khanna R, Evans CD, Lu M, et al. Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials. JAMA Neurol. 2025;82(5):461-9. 2025-08-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207367 Bulletin BiblioDem 2025-22-3 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants ont été analysés : 1. Coughlan GT, Klinger HM, Boyle R, Betthauser TJ, Binette AP, Christenson L, et al. Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis. JAMA Neurol. 2025;82(4):364-75. 2. Duggan MR, Paterson C, Lu Y, Biegel H, Dark HE, Cordon J, et al. The Dementia SomaSignal Test (dSST): A plasma proteomic predictor of 20-year dementia risk. Alzheimers Dement. 2025;21(2):e14549. 3. Gong Y, Chen H, Gu Y, Shen J, Shen T, Ding Y, et al. Healthy dietary patterns in relation to cognitive performance and Alzheimer's disease mortality. J Prev Alzheimers Dis. 2025;12(5):100100. 4. Harrison KL, Morgan BE, Friend J, Garrett SB, Looi D, Halim M, et al. "By the Time We Knew ...": Poetic Analysis of End-of-Life Caregiving Experiences for Rapidly Progressive and Slower-Duration Dementia Syndromes. J Am Geriatr Soc. 2025(5):1406-18. 5. Llibre-Guerra JJ, Fernandez MV, Joseph-Mathurin N, Bian S, Carter K, Li Y, et al. Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia. Nat Med. 2025(4):1267-75. 6. Nihart AJ, Garcia MA, El Hayek E, Liu R, Olewine M, Kingston JD, et al. Bioaccumulation of microplastics in decedent human brains. Nat Med. 2025;31(4):1114-9. 7. Octary T, Fajarini M, Arifin H, Chen R, Sung CM, Chang LF, et al. Multisensory stimulation reduces neuropsychiatric symptoms and enhances cognitive function in older adults with dementia: A meta-analysis of randomized controlled trials. J Prev Alzheimers Dis. 2025;12(5):100091. 8. Rosen J, Jessen F. Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's disease. J Prev Alzheimers Dis. 2025;12(4):100102. 2025-06-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207366 Bulletin BiblioDem 2025-22-2 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants ont été analysés : 1. Cai Y, Fang L, Li A, Yang J, Zhou X, He Z, et al. Educational attainment, Abeta, tau, and structural brain reserve in Alzheimer's disease. Alzheimers Dement. 2025;21(2):e14400. 2. Coley N, Hoevenaar-Blom MP, Shourick J, van Charante EPM, van Dalen JW, van Gool WA, et al. Searching for responders to multidomain dementia prevention in late life: A pooled analysis of individual participant data from the MAPT and preDIVA trials. Alzheimers Dement. 2025;21(2):e14472. 3. Farmer JG, Macchia L, Bu F, Gong J, Steptoe A, Demakakos P, et al. Prosocial Intentions and Subsequent Cognitive Health: A Prospective Cohort Study. J Gerontol B Psychol Sci Soc Sci. 2025;80(3). 4. Karakose S, Luchetti M, Stephan Y, Sutin AR, Terracciano A. Life satisfaction and risk of dementia over 18 years: an analysis of the National Alzheimer's Coordinating Center dataset. Geroscience. 2025;47(1):1319-28. 5. Westphal Filho FL, Moss Lopes PR, Menegaz de Almeida A, Sano VKT, Tamashiro FM, Goncalves OR, et al. Statin use and dementia risk: A systematic review and updated meta-analysis. Alzheimers Dement (N Y). 2025;11(1):e70039. 6. Wiels WA, Oomens JE, Engelborghs S, Baeken C, von Arnim CAF, Boada M, et al. Depressive Symptoms and Amyloid Pathology. JAMA Psychiatry. 2025;82(3):296-310. 7. Williams ME, Fennema-Notestine C, Bell TR, Lin SJ, Glatt SJ, Kremen WS, et al. Neuroimaging Predictors of Cognitive Resilience against Alzheimer's Disease Pathology. Ann Neurol. 2025;97(6):1038-50. 2025-04-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207961 Bulletin BiblioDem 2025-22-5 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants sont analysés :1. Cai Y, Fang L, Yang J, Zhou X, Liu L, Li A, et al. Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease. JAMA Neurol. 2025;82(8):848-58. 2. Chou YC, Han ML, Chiu THT, Lee MS, Chiou JM, Chen JH, et al. Longitudinal Association of Inflammatory Diets on Cognition in Older Adults: Insights from the Oral-Gut-Brain Axis. J Am Geriatr Soc. 2025;73(9):2747-56. 3. Ma'u E, Cullum S, Rohr S, Brayne EC. Are modifiable risk factors for dementia really modifiable? Curr Opin Psychiatry. 2025;38(5):348-54. 4. Mila-Aloma M, Tosun D, Schindler SE, Hausle I, Petersen KK, Li Y, et al. Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks. Ann Neurol. 2025;98(3):508-23. 5. Mitchell JJ, Hamer M, James SN, Norris T, Jefferis BJ, Wannamethee SG, et al. Bidirectional associations of Physical Activity and Cognitive Function in Midlife Adults: A Longitudinal Analysis across 26 years follow-up. Am J Epidemiol. 2025. 6. Paczynski M, Hofmann A, Posey Z, Gregersen M, Rudman M, Ellington D, et al. Lecanemab Treatment in a Specialty Memory Clinic. JAMA Neurol. 2025;82(7):655-65. 7. Pichet Binette A, Smith R, Salvado G, Tideman P, Glans I, van Westen D, et al. Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease. JAMA Neurol. 2025;82(7):666-75. 8. Piura YD, Satyadev N, Corriveau-Lecavalier N, Kuchenbecker LA, Haydu LE, Geschwind MD, et al. Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia. Ann Neurol. 2025;98(4):764-76. 9. Qian Y, Pomeroy ML, Petchler CM, Abshire Saylor M, Cudjoe TKM, Ornstein KA. The Epidemiology of Social Isolation and Loneliness Among Family and Unpaid Caregivers of Older Adults: Findings From the National Study of Caregiving. J Gerontol B Psychol Sci Soc Sci. 2025;80(7). 10. Skillback TB, Jonsson L, Skoog I, Blennow K, Eriksdotter M, Zetterberg H, et al. Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia. JAMA Neurol. 2025;82(6):580-8. 11. Smith JR, Pike JR, Gottesman RF, Knopman DS, Lutsey PL, Palta P, et al. Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia. JAMA Neurol. 2025;82(7):644-54. 12. Walsemann KM, Jackson HM, Boardman JD, Herd P. APOE genotype and cognitive decline: educational context as a moderator of genetic risk. J Gerontol B Psychol Sci Soc Sci. 2025;80(8). 2025-12-10T00:00:00Z